Strata Critical Medical, Inc.
SRTAHealthcareNASDAQMedical Care Facilities
Scan Results
Daily timeframeStrata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. Valued at $412.3M, SRTA is a small-cap name in its sector. It operates in two segments, Logistics and Clinical.
Market Cap
$412.3M
Beta
2.43
P/E (TTM)
—
P/E (Fwd)
—
EPS (TTM)
$-0.28
EPS (Fwd)
—
ROE
-9.2%
ROA
-1.9%
Cash
$22.8M
Total Debt
$4.3M
Free CF
-$20.1M
52W Change
-7.4%
Annual Financials
Cash vs Debt
Where SRTA stands vs its 150-day and 200-day moving averages
As of the October 19, 2026 close, SRTA finished 12.86% below its 150-day moving average ($5.21) and 11.67% below its 200-day moving average ($5.14). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is SRTA overbought or oversold?
At the October 19, 2026 close, SRTA's RSI(14) was 27.4, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Strata Critical Medical, Inc. holds $22.8M in cash against $4.3M in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Free cash flow is running at -$20.1M, which bears watching. Negative free cash flow can be acceptable during heavy investment periods but needs to improve over time. Return on equity stands at -9.2%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Revenue has grown from $146.1M (2022) to $197.1M (2025), reflecting a 35% increase over the period.
A beta of 2.43 means SRTA is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. The strong cash position relative to debt provides a financial cushion that reduces balance sheet risk. The company is burning cash at the operating level, which is not unusual for growth-phase companies but adds risk if it persists. No single metric tells the full story. Reviewing SRTA's risk profile alongside its fundamentals and technical indicators provides a more complete picture.